Medical Device Secondary Packaging Outlook to 2035: Compliance and E-commerce Drive 5.8% Annual Growth
Impact level
⚪ Background
What happened
IndexBox published a report on October 7, 2026, forecasting a 5.8% compound annual growth rate for the global medical device secondary packaging market from 2026 to 2035, with the market index reaching 176 in 2035 (2025=100). Growth drivers include higher traceability and labeling requirements under EU MDR and IVDR, as well as expansion of e-commerce and direct-to-patient channels. Constraints include raw material price volatility and supply chain disruptions. Asia-Pacific leads in sales volume growth, while North America and Europe remain centers of innovation and premiumization. End-user shares are OEMs 35%, contract packagers 25%, hospitals and clinics 20%, retail pharmacies and supermarkets 12%, and other 8%. [1]
Involves:Medical device secondary packaging、Sterile barrier system、Serialization labels
Seller impact
- ScenarioRegulatory requirements are driving higher traceability, labeling, and sterile barrier standards, increasing demand for serialization and tamper-evident packaging; the outsourcing trend benefits contract packagers (25%). This is a report forecast, not evidence of an actual shift in orders. [1]
- InferenceRaw material price volatility and supply chain disruptions are cited as constraints, but the report provides no figures for the cost shares of polymers or specialty paper, price increases, or pass-through rates. The impact on finished device or packaging prices therefore cannot be quantified. [1]
Suggested action
Verify that your packaging meets EU MDR/IVDR labeling and serialization requirements, and confirm the drop-test standards for e-commerce shipments.
Evidence that would disprove the assessment
- Assessment 1:This assessment would no longer hold if future revisions to EU MDR/IVDR relaxed labeling or serialization requirements, or if data on OEM outsourcing were revised downward.
- Assessment 2:Specific figures on raw material cost shares or price pass-through disclosed in a future report could overturn this assessment that the impact cannot be quantified.